At the news
? NEUTRALIMPACT 2/10 PRESS-RELEASE filed Apr 3, 2026 at 16:30 ET
ORIC Pharmaceuticals announced the grant of stock options and restricted stock units to a new non-executive employee as an inducement to employment, approved under Nasdaq Rule 5635(c)(4). The move is a routine hiring incentive and does not reflect a material change in the company's operations or financial condition.
- ORIC granted 80,000 non-qualified stock options and 15,000 restricted stock units to a new non-executive employee.
- Grants were made on April 1, 2026, under the 2022 Inducement Equity Incentive Plan.
- Stock options vest 25% after one year, with the remainder vesting monthly over 36 months; RSUs vest in thirds over three years.
- The Compensation Committee approved the grants in accordance with Nasdaq rules for inducement awards.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access